Net Income (Loss) Attributable to Parent in USD of Vigil Neuroscience, Inc. from Q1 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vigil Neuroscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q2 2025.
  • Vigil Neuroscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$26.7M, a 25.6% decline year-over-year.
  • Vigil Neuroscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$92.2M, a 9.94% decline year-over-year.
  • Vigil Neuroscience, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$84.3M, a 1.96% decline from 2023.
  • Vigil Neuroscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$82.6M, a 21% decline from 2022.
  • Vigil Neuroscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.3M, a 57.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Vigil Neuroscience, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$92.2M -$26.7M -$5.44M -25.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 -$86.7M -$22.4M -$2.47M -12.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-08-05
Q4 2024 -$84.3M -$23.8M -$1.66M -7.47% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 -$82.6M -$19.3M +$1.24M +6.04% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$83.8M -$21.2M -$1.05M -5.22% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 -$82.8M -$19.9M -$145K -0.73% Jan 1, 2024 Mar 31, 2024 10-Q 2025-08-05
Q4 2023 -$82.6M -$22.2M -$3.72M -20.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 -$78.9M -$20.5M -$3M -17.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$75.9M -$20.2M -$3.16M -18.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$72.8M -$19.8M -$4.46M -29.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$68.3M -$18.5M -$5.47M -42.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-13
Q3 2022 -$62.8M -$17.5M -$6.76M -62.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$56.1M -$17M -$5.65M -49.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$50.4M -$15.3M -$7.14M -87.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$43.3M -$13M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 -$10.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$8.19M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10

Vigil Neuroscience, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$84.3M -$1.62M -1.96% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$82.6M -$14.3M -21% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 -$68.3M -$25M -57.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2021 -$43.3M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.